A Mendelian randomization study with bioinformatics analysis reveals gut microbiota mediates in heart failure and Alzheimer’s disease via BAFF-R
Authors:
- 23 January 2026
- journal article
- Published by Elsevier in Neuroscience
- Vol. 597, 27-37
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81870850)
This publication has 51 references indexed in Scilit:
- Heart failure management guidelines: New recommendations and implementationJournal of Cardiology, 2023
- The associations of serum valine with mild cognitive impairment and Alzheimer’s diseaseAging Clinical and Experimental Research, 2022
- Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s DementiaMolecular Neurobiology, 2020
- Association of branched‐chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohortsAlzheimer's & Dementia, 2018
- Interpreting findings from Mendelian randomization using the MR-Egger methodEuropean Journal of Epidemiology, 2017
- Milder Alzheimer's disease pathology in heart failure and atrial fibrillationAlzheimer's & Dementia, 2017
- Heart Failure and Risk of Dementia: A Danish Nationwide Population-Based Cohort StudyEuropean Journal of Heart Failure, 2016
- Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levelsAlzheimer's & Dementia, 2016
- Structural brain alterations in heart failure: a review of the literature and implications for risk of Alzheimer’s diseaseHeart Failure Reviews, 2015
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiologyStatistics in Medicine, 2008